One-of-a-Kind drug created for single ALS patient
NCT ID NCT07423494
Summary
This study is testing a custom-made drug designed for a single person with ALS caused by a specific genetic mutation. The goal is to see if the drug is safe and if it can help slow the progression of the disease over one year. The study will carefully track the participant's physical function, strength, breathing, and thinking.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.